Thermal Ink-Jet Technology Prints on Non-porous Surfaces - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Thermal Ink-Jet Technology Prints on Non-porous Surfaces


The Videojet 8610 thermal ink-jet printer from Videojet Techologies uses fast-drying inks to provide high-resolution print on non-porous packaging materials including films, foils, plastics, and coated stocks. The technology allows in-line printing of multi-line codes and other high resolution marks, including DataMatrix and QR codes, without modifying packaging designs.  The patented cartridge is a fully contained, high-resolution print cartridge designed specifically to jet MEK-based inks. An automated Cartridge Readiness System allows consistent print performance that is unaffected by the frequency or length of common line interruptions. Print resolutions can be up to four times greater than continuous ink-jet technology, resulting in near-letter quality printing with excellent edge acuity. The system is designed for minimal maintenance.  

Source: Videojet Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here